Literature DB >> 8436291

Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes.

K S Ullman1, J P Northrop, A Admon, G R Crabtree.   

Abstract

The octamer-binding transcription factor Oct-1 is involved in a wide variety of cellular processes but appears to lack a strong transcriptional activation domain, suggesting that it functions in the context of other proteins. We demonstrated previously that Oct-1, in association with a 40-kD protein, OAP40, contributes to the induction of interleukin-2 (IL-2), an early activation gene and major growth factor for T lymphocytes. Here we report that amino acid sequences obtained from purified OAP40 are identical to regions within JunD and c-Jun. We demonstrate that each of these Jun family members can participate in a complex that includes Oct-1 and a regulatory element in the IL-2 enhancer. In transient transfections, both JunD and c-Jun can contribute to activation-specific transcription mediated by this antigen receptor response element. These studies reveal a role, distinct from AP-1 activity, for Jun family members that is controlled by a calcium-triggered, cyclosporin A-sensitive mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436291     DOI: 10.1101/gad.7.2.188

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

1.  The tumour associated cell surface antigen A6H is costimulatory for human CD4+ but not CD8+ T cells.

Authors:  T Labuda; E Parra; G Hedlund; T Kalland; M Dohlsten
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes.

Authors:  G Baier-Bitterlich; F Uberall; B Bauer; F Fresser; H Wachter; H Grunicke; G Utermann; A Altman; G Baier
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Distinct variant DNA-binding sites determine cell-specific autoregulated expression of the Drosophila POU domain transcription factor drifter in midline glia or trachea.

Authors:  K Certel; M G Anderson; R J Shrigley; W A Johnson
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.

Authors:  T D Batiuk; L Kung; P F Halloran
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.

Authors:  Sungeun Kim; Christopher T Denny; Ron Wisdom
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase.

Authors:  P Ling; Z Yao; C F Meyer; X S Wang; W Oehrl; S M Feller; T H Tan
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

7.  Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.

Authors:  R J Bram; D T Hung; P K Martin; S L Schreiber; G R Crabtree
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

9.  Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in T cells: involvement of the conserved lymphokine element 0.

Authors:  A Tsuboi; E S Masuda; Y Naito; H Tokumitsu; K Arai; N Arai
Journal:  Mol Biol Cell       Date:  1994-01       Impact factor: 4.138

10.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.